Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $43.5000 (6.88%) ($39.8000 - $43.8000) on Tue. Sep. 25, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.93% (three month average) | RSI | 61 | Latest Price | $43.5000(6.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.465% in a week (0% probabilities). VXX(-14%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.465% (StdDev 2.93%) | Hourly BBV | 0 () | Intraday Trend | 6.4% | | | |
|
5 Day Moving Average | $40.97(6.18%) | 10 Day Moving Average | $40.61(7.12%) | 20 Day Moving Average | $40.32(7.89%) | To recent high | 0% | To recent low | 24.1% | Market Cap | $3.232b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |